Dr. Andrew M. Brunner, MD

Dr. Brunner practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Brunner's NPI, 1699095166, was assigned on June 8, 2010. Dr. Brunner graduated from Warren Alpert Medical School of Brown University in 2010. Dr. Brunner holds Massachusetts license 252646.

Dr. Brunner's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Brunner's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Brunner is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Hospital. Dmand AI also links Dr. Brunner to 3 more hospitals, 2 group practices and clinics, 1 community health center and 1 medical group, each named with a free account. Dr. Brunner's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brunner practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Brunner's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Brunner is licensed in Massachusetts.

CMS data shows 850 Medicare services from Dr. Brunner across 6 procedure codes in 2024, for 153 Medicare patients. Medicare paid $68,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Brunner in 2024. The largest group is 75 to 84, with 71 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 12% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Brunner's median patient age at 77, with 43% women.

In 2024, Dr. Brunner wrote 230 Medicare Part D claims for 44 patients. 76% of them were for generic drugs. CMS names the drug for 85 of them, across 5 drugs with 11 or more claims each, at $97,936 in total drug cost. In 2023, CMS named 116 claims across 4 drugs.

Dr. Brunner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Brunner as offering telehealth.

Dmand AI links 133 papers to Dr. Brunner, published from 2011 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Hematopoietic Stem Cell Transplantation. Dr. Brunner has published most often in Leuk Res. Dr. Brunner's most frequent co-authors are Amer Zeidan, Karen K. Ballen, MD and Gail J. Roboz, MD.

Dmand AI links Dr. Brunner to 6 clinical trials, 3 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases and Leukemia. Massachusetts General Hospital sponsors the most, 2.

CMS Open Payments shows 130 general payments to Dr. Brunner from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. Novartis Pharmaceuticals Corporation paid the most, $33,430. It also lists 11 research payments totaling $37,759 from 2018 to 2022.

Dr. Brunner graduated from Warren Alpert Medical School of Brown University in 2010.